Longitudinal Associations Between Flavored Tobacco Use and Tobacco Product Cessation in a National S
Friday, July 15, 2022
Posted by: Natalia Gromov
Steeger CM, Harlow AF,
Barrington-Trimis J, Simon P, Hill KG, Leventhal AM.
Longitudinal Associations
Between Flavored Tobacco Use and Tobacco Product Cessation in a National Sample
of Adults.
[published online ahead of print, 2022 Jul 5]. Prev Med. 2022;107143.
doi:10.1016/j.ypmed.2022.107143
Use of flavored tobacco has been associated with lower likelihood of short-term
abstinence from tobacco. It is unknown whether longer-term associations exist,
particularly for a variety of products and specific flavor categories. Using
adult survey data from the Population Assessment of Tobacco and Health (PATH)
Study (2013-2018), we tested associations of past 30-day tobacco product use at
wave 2 using both a 2-category any flavor versus unflavored variable and
4-category specific flavor (menthol/mint, sweet, and both menthol/mint and
sweet) versus unflavored variable with past 12-month cessation from the same product
two years later at wave 4. Separate models were run for each product
(combustible cigarettes, cigars, hookah, e-cigarettes, and smokeless),
adjusting for wave 1 sociodemographic characteristics. For all five products,
past 30-day use of any flavored (versus unflavored) product at wave 2 was
associated with reduced likelihood of same-product cessation at wave 4. Most
specific flavor categories were associated with reduced odds of same-product
cessation across all products. Any flavor use was also associated with reduced
likelihood of longer-term cessation (i.e., past 24-months at both waves 3 and
4) and cessation from all five tobacco products for most products. Exploratory
moderation results indicated that the association between e-cigarette flavor use
and lower likelihood of cessation was stronger for young adults (18-24) versus
older adults (25+). Current use of flavored tobacco products is associated with
lower likelihood of product cessation. Flavored tobacco products warrant
consideration in regulatory policy to reduce the adverse public health impact
of tobacco use.
|
|
Email to a Friend